Fournier gangrene in an immunosuppressed patient due to cancer chemotherapy

Authors

  • José Ramón Rodríguez Morales Hospital Asistencial “Celestino Hernández Robau”, Santa Clara, Villa Clara
  • Ernesto Romagosa Bermúdez Hospital Asistencial “Celestino Hernández Robau”, Santa Clara, Villa Clara
  • Eduardo Ibáñez Carrillo Hospital Asistencial “Celestino Hernández Robau”, Santa Clara, Villa Clara

Keywords:

Fournier gangrene, adjuvant chemotherapy

Abstract

Fournier gangrene is a potentially fatal necrotizing fasciitis that occurs as a result of a polybacterial infectious process that affects especially the perineum, genitals and perianal tissue. The case of a 46-year-old patient is reported. She was given a course of chemotherapy due to suffering from a nodular cutaneous scalp melanocarcinoma with cervical lymph node and pulmonary metastasis. One week after being administered the scheme she was diagnosed with Fournier gangrene in the soft parts of the perineum, the vulva and perianal tissue, starting about an ulcerative mucositis of the rectal mucosa associated with neutropenia due to cytostatics.

 

 

Downloads

Download data is not yet available.

Downloads

How to Cite

1.
Rodríguez Morales JR, Romagosa Bermúdez E, Ibáñez Carrillo E. Fournier gangrene in an immunosuppressed patient due to cancer chemotherapy. Acta Méd Centro [Internet]. 2013 Oct. 7 [cited 2025 Jun. 27];7(3):101-4. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/169

Issue

Vol. 7 No. 3 (2013): July-September

Section

Oncology

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).